Literature DB >> 7080438

Bovid herpesvirus type-1 (infectious bovine rhinotracheitis virus)-induced thymidine kinase.

G A Weinmaster, V Misra, R McGuire, L A Babiuk, E DeClercq.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7080438     DOI： 10.1016/0042-6822(82)90332-4

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  12 in total

1.  Map location of the thymidine kinase gene of bovine herpesvirus 1.

Authors:  L J Bello; J C Whitbeck; W C Lawrence
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  Characterization of an Epstein-Barr virus-induced thymidine kinase.

Authors:  M de Turenne-Tessier; T Ooka; G de The; J Daillie
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

3.  Acyclic guanosine analogs as substrates for varicella-zoster virus thymidine kinase.

Authors:  A R Karlström; C F Källander; G Abele; A Larsson
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

4.  Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.

Authors:  T Sakuma
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

5.  Genome structure and virion polypeptides of the primate herpesviruses Herpesvirus aotus types 1 and 3: comparison with human cytomegalovirus.

Authors:  A Ebeling; G Keil; B Nowak; B Fleckenstein; N Berthelot; P Sheldrick
Journal:  J Virol       Date:  1983-02       Impact factor: 5.103

6.  Nucleotide and amino acid sequence analysis of the thymidine kinase gene of a bovine encephalitis herpesvirus.

Authors:  G A Smith; P L Young; J S Mattick
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Inhibition of glycosylation of bovine herpesvirus 1 glycoproteins by the thymidine analog (E)-5-(2 Bromovinyl)-2'-deoxyuridine.

Authors:  V Misra; R C Nelson; L A Babiuk
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

8.  Transcriptional analysis of the bovine herpesvirus 1 Cooper isolate. Temporal analysis and characterization of immediate-early, early, and late RNA.

Authors:  B S Seal; J M Irving; C A Whetstone
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

9.  Relative activities of acyclovir and BW759 against Aujeszky's disease and equine rhinopneumonitis viruses.

Authors:  E A Rollinson; G White
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

Review 10.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.